Call us on +34 960 451 185
Patient Portal
International
Brasil Chile Deutschland España France International Italia Panamá Portugal UK
IVI Fertility International
    • ASSISTED REPRODUCTION

      • Artificial Insemination (AI)
      • In Vitro Fertilisation (IVF)
      • IVF Genetic
      • Reciprocal IVF
      • Egg donation
      • Preservation of Fertility
    • -

      • Highly Complex Reproduction
      • Surrogacy
      • Family Balance
      • Known egg donation
      • Non-Anonymous Egg Donation
      • View all our treatments >
    • ANSWER YOUR QUESTIONS

      • Causes of infertility
      • Your first visit to IVI
      • Egg Donation Program in Spain
      • Egg Donation Program in Portugal
    • OUR RESULTS

      • Success rates
    • ADVANCED TECHNIQUES

      • Vitrification of oocytes
      • Perfect Match 360º
      • IA EMBRYOSELECT
      • Semen Donation
      • ICSI
      • MACS
    • MEDICAL SPECIALITIES

      • Ovarian rejuvenation
    • GENETIC TESTS

      • CARRIER Expanded (Genetic Carrier Screening Test)
      • Preimplantation Genetic Testing (PGT)
      • Non-Invasive Prenatal Tests
    • Donors

      • IVI: one of the world’s largest egg banks
    • -

      • Prices
    • IVI PLANS

      • Fly and Care
      • IVI Baby Plan
    • Spain

      • A Coruña
      • Alicante
      • Almeria
      • Barcelona
      • Bilbao
      • Burgos
      • Cartagena
      • Castellon
    • -

      • Donostia
      • Girona
      • Ibiza
      • Las Palmas
      • Madrid – Alcorcón
      • Madrid – Aravaca
      • Madrid – Norte
      • Málaga
    • -

      • Mallorca – Manacor
      • Mallorca – Palma
      • Murcia
      • Pamplona
      • Salamanca
      • Santander
      • Tenerife
    • -

      • Valencia
      • Valladolid
      • Vigo
      • Vitoria
      • Zaragoza
    • Portugal

      • Lisboa
    • United Kingdom

      • London
    • Italy

      • Milano
      • Roma Lancisi
      • Bologna
    • Panama

      • Panama
    • Brazil

      • Salvador
    • Chile

      • Santiago de Chile
    • About IVI Fertility

      • Get to know us
      • Medical team
    • CONTENTS

      • Blog
      • Press room
Make an appointment
  • ASSISTED REPRODUCTION

    • Artificial Insemination (AI)
    • In Vitro Fertilisation (IVF)
    • IVF Genetic
    • Reciprocal IVF
    • Egg donation
    • Preservation of Fertility
  • -

    • Highly Complex Reproduction
    • Surrogacy
    • Family Balance
    • Known egg donation
    • Non-Anonymous Egg Donation
    • View all our treatments >
  • ANSWER YOUR QUESTIONS

    • Causes of infertility
    • Your first visit to IVI
    • Egg Donation Program in Spain
    • Egg Donation Program in Portugal
  • OUR RESULTS

    • Success rates
  • ADVANCED TECHNIQUES

    • Vitrification of oocytes
    • Perfect Match 360º
    • IA EMBRYOSELECT
    • Semen Donation
    • ICSI
    • MACS
  • MEDICAL SPECIALITIES

    • Ovarian rejuvenation
  • GENETIC TESTS

    • CARRIER Expanded (Genetic Carrier Screening Test)
    • Preimplantation Genetic Testing (PGT)
    • Non-Invasive Prenatal Tests
  • Donors

    • IVI: one of the world’s largest egg banks
  • -

    • Prices
  • IVI PLANS

    • Fly and Care
    • IVI Baby Plan
  • Spain

    • A Coruña
    • Alicante
    • Almeria
    • Barcelona
    • Bilbao
    • Burgos
    • Cartagena
    • Castellon
  • -

    • Donostia
    • Girona
    • Ibiza
    • Las Palmas
    • Madrid – Alcorcón
    • Madrid – Aravaca
    • Madrid – Norte
    • Málaga
  • -

    • Mallorca – Manacor
    • Mallorca – Palma
    • Murcia
    • Pamplona
    • Salamanca
    • Santander
    • Tenerife
  • -

    • Valencia
    • Valladolid
    • Vigo
    • Vitoria
    • Zaragoza
  • Portugal

    • Lisboa
  • United Kingdom

    • London
  • Italy

    • Milano
    • Roma Lancisi
    • Bologna
  • Panama

    • Panama
  • Brazil

    • Salvador
  • Chile

    • Santiago de Chile
  • About IVI Fertility

    • Get to know us
    • Medical team
  • CONTENTS

    • Blog
    • Press room
Make an appointment
Call us
Contact us

26 October 2026

A treatment derived from umbilical cord blood manages to regenerate the endometrium in women with complex uterine pathologies

Home Press room A treatment derived from umbilical cord blood manages to regenerate the endometrium in women with complex uterine pathologies

  • IVI Institute presents a study at the American Society for Reproductive Medicine (ASRM) showing an improvement in endometrial vascularization and functionality after the administration of platelet-rich plasma from the umbilical cord
  • The technique is aimed at women with thin endometrium, Asherman’s syndrome or endometrial atrophy, patients who currently have limited therapeutic options
  • Preliminary results point to a promising avenue to promote embryo implantation, female fertility, endometrial quality and improve reproductive health

In assisted reproduction, much of the attention tends to focus on the quality of the embryos. However, for pregnancy to occur, it is also essential that the endometrium, the tissue that lines the inside of the uterus, is capable of receiving and sustaining embryo implantation. When this capacity is altered, achieving pregnancy becomes a particularly complex clinical challenge.

With the aim of offering new alternatives to these patients, researchers from the IVI Institute Foundation have presented  a study at the annual meeting of the American Society for Reproductive Medicine (ASRM) that analyzes the regenerative potential of platelet-rich plasma (PRP) from umbilical cord blood in women with severe endometrial pathologies.

The research has focused on women with Asherman’s syndrome, thin endometrium or endometrial atrophy, alterations that make it difficult for the tissue to reach the necessary conditions to allow the embryo to implant.

“These patients have a particularly complex problem because their endometrium has a limited regenerative capacity. By not having functional and adequately developed tissue, the chances of embryo implantation decrease considerably,” explains Dr. Irene Cervelló, principal investigator of the study and of the IVI Institute Foundation and La Fe Health Research Institute (IIS LAFE).

The treatment consists of administering a subendometrial injection of platelet-rich plasma obtained from donated umbilical cord blood by hysteroscopy. Unlike conventional PRP, which is usually obtained from the patient’s own blood, this strategy uses a much younger biological source enriched in proteins, biomolecules and growth factors that can promote endometrial regeneration.

New blood vessels to restore tissue functionality

One of the main findings of the study is that the treatment favors neoangiogenesis, i.e., the formation of new blood vessels in the endometrium. The proportion of neoangiogenic vascular area increased from 32.23% before treatment to 45.60% after administration of umbilical cord PRP.

The researchers believe that this increase in vascularization could play a relevant role in tissue recovery.

“The new vascularization allows blood, oxygen, growth factors and the necessary signals for the endometrium to regenerate and become functional again. Having observed this neoangiogenesis indicates that the treatment is producing a real biological effect on the tissue,” says Cervelló.

Promising results in patients with few alternatives

The pilot study was carried out in 15 patients treated at IVI Fertility Valencia and the Hospital Universitari i Politècnic La Fe in Valencia. According to Cervelló, almost all of the women included experienced an improvement in endometrial thickness and functionality after treatment.

Although reproductive outcomes will need to be confirmed in larger studies, the findings suggest that improving vascularization and endometrial regeneration could help restore a more favorable environment for embryo implantation.

“Our goal is to offer an alternative to women who currently have very few reproductive options when their endometrium does not respond to conventional treatments. The results are preliminary, but they open a very promising avenue for this group of patients,” says Cervelló.

Next step: Demonstrating the impact on pregnancy

The team is currently developing a new multicenter study with 35 patients in IVI Fertility centers, approved by the National Transplant Organization (ONT by its Spanish acronym) to validate the results obtained and determine if the improvement observed in the endometrium also translates into higher implantation and pregnancy rates.

“I think one of the most important messages is that the endometrium deserves more attention in reproductive medicine. Often the focus is on the embryo, but for proper implantation to take place, we also need a prepared and functional endometrium. Our work provides a new piece to understand how we can promote the regeneration of tissue that, in some patients, has a limited capacity to recover,” concludes the researcher.

Share on social networks

twitter facebook

Share on social networks

twitter facebook

PRESS ROOM CONTACTS

  • Ricardo Pedrós
  • Email: prensa@ivi.es
  • Phone number: (0034) 96 317 36 10
  • Calle Colón, 1 - 46004 (Valencia)

Request more information, no obligation

Sending

Thank you,

One of our agents will contact you from the phone number Teléfono pide cita

IVI Fertility International

Call us on +34 960 451 185

Make an appointment

Experts in fertility

  • Assisted reproduction treatments
  • Clinics
  • Egg Donation Program in Spain
  • FAQs

Learn about us

  • IVI Institute
  • Jobs at IVI Fertility

Head Offices

  • Calle Colón 1, 4ª planta, 46004 Valencia. España.

Quality stamps

  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • Legal Notice
  • Cookies Policy
  • Whistleblowing Policy
  • Internal information channel